Grifols Stock
Grifols Stock price
Key metrics
| Market capitalization | €6.96b |
| Enterprise Value | €18.19b |
| P/E (TTM) P/E ratio | 44.27 |
| EV/Sales (TTM) EV/Sales | 2.77 |
| P/S ratio (TTM) P/S ratio | 1.06 |
| P/B ratio (TTM) P/B ratio | 1.24 |
| Revenue (TTM) Revenue | €6.57b |
| EBIT (operating result TTM) EBIT | €857.73m |
| Cash position | €2.11b |
Is Grifols a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,912 stocks worldwide.
Grifols Stock Analysis
Analyst Opinions
15 Analysts have issued a Grifols forecast:
Analyst Opinions
15 Analysts have issued a Grifols forecast:
Financial data from Grifols
| Jun '24 |
+/-
%
|
||
| Net Profit | 157 157 |
1,767%
1,767%
|
|
| Depreciation and Amortization | 442 442 |
1%
1%
|
|
| Stock Compensation | - - |
-
|
|
| Operating Cash Flow | - - |
-
|
|
| Investments | - - |
-
|
|
| Dividend Paid | - - |
-
|
|
| Free Cash Flow | - - |
-
|
|
In millions EUR.
Don't miss a Thing! We will send you all news about Grifols directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.
| Head office | Spain |
| CEO | Nacho Abia |
| Employees | 23,744 |
| Founded | 1940 |
| Website | www.grifols.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
